{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T10:32:21Z","timestamp":1785148341387,"version":"3.55.0"},"reference-count":43,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T00:00:00Z","timestamp":1689206400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Mol. Biosci."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> Despite highly effective treatments to cure hepatitis C, almost 80% of chronically HCV-infected people are not treated, as they are unaware of their infection. Diagnostic rates and linkage to care must be substantially improved to reverse this situation. The HCV core antigen (HCVcAg) is a highly conserved protein that can be detected in the blood of HCV-infected patients and indicates active infection.<\/jats:p><jats:p><jats:bold>Aim:<\/jats:bold> To produce murine monoclonal antibodies against HCVcAg suitable for rapid and inexpensive tests to detect HCV infection.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> BALB\/c mice were sequentially inoculated with purified recombinant HCVcAg from Gt1a, Gt3a, Gt4a, and Gt1b genotypes. Hybridomas producing the desired monoclonal antibodies were selected, and the reactivity of antibodies against HCVcAg from various genotypes was tested by Western blotting and dot blotting. The binding kinetics of the antibodies to purified HCVcAg was analyzed by surface plasmon resonance (SPR), and their ability to detect HCVcAg was tested by double antibody sandwich ELISA (DAS-ELISA).<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> Four specific monoclonal antibodies (1C, 2C, 4C, and 8C) were obtained. 1C, 2C, and 4C recognized HCVcAg of all genotypes tested (Gt1a, Gt1b, Gt2a, Gt3a, and Gt4a), while 8C did not recognize the Gt2a and Gt3a genotypes. Based on SPR data, the antibody-HCVcAg complexes formed are stable, with 2C having the strongest binding properties. DAS-ELISA with different antibody combinations easily detected HCVcAg in culture supernatants from HCV-infected cells.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> Specific and cross-reactive anti-HCVcAg monoclonal antibodies with strong binding properties were obtained that may be useful for detecting HCVcAg in HCV-infected samples.<\/jats:p>","DOI":"10.3389\/fmolb.2023.1225553","type":"journal-article","created":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T23:17:53Z","timestamp":1689290273000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Production and characterization of monoclonal antibodies for the detection of the hepatitis C core antigen"],"prefix":"10.3389","volume":"10","author":[{"given":"Erick Joan","family":"Vidal-Alc\u00e1ntara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicente","family":"Mas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Bel\u00e9n","family":"Y\u00e9lamos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juli\u00e1n","family":"G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Amigot-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvador","family":"Resino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isidoro","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,7,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.eimc.2020.02.003","article-title":"Current position of viral load versus hepatitis C core antigen testing","volume":"38","author":"Aguilera","year":"2020","journal-title":"Enferm. Infecc. Microbiol. Clin. Engl. Ed."},{"key":"B2","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1089\/hyb.1985.4.277","article-title":"Clonal stability and heterogeneity of hybridomas: Analysis by multiparameter flow cytometry","volume":"4","author":"Andreeff","year":"1985","journal-title":"Hybridoma"},{"key":"B3","doi-asserted-by":"publisher","first-page":"11353","DOI":"10.1128\/JVI.79.17.11353-11365.2005","article-title":"Hepatitis C virus core protein is a dimeric alpha-helical protein exhibiting membrane protein features","volume":"79","author":"Boulant","year":"2005","journal-title":"J. Virol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"8239","DOI":"10.1073\/pnas.91.17.8239","article-title":"Sequence analysis of the core gene of 14 hepatitis C virus genotypes","volume":"91","author":"Bukh","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B5","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1128\/cdli.4.2.117-121.1997","article-title":"Improved reactivity of hepatitis C virus core protein epitopes in a conformational antigen-presenting system","volume":"4","author":"Buratti","year":"1997","journal-title":"Clin. Diagn Lab. Immunol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1111\/j.1469-0691.2010.03281.x","article-title":"Routine use of point-of-care tests: Usefulness and application in clinical microbiology","volume":"16","author":"Clerc","year":"2010","journal-title":"Clin. Microbiol. Infect."},{"key":"B7","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1093\/cid\/ciu782","article-title":"Hepatitis C core antigen testing: A reliable, quick, and potentially cost-effective alternative to hepatitis C polymerase chain reaction in diagnosing acute hepatitis C virus infection","volume":"60","author":"Cresswell","year":"2015","journal-title":"Clin. Infect. Dis."},{"key":"B8","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.coviro.2015.04.002","article-title":"Strategies to guide the antibody affinity maturation process","volume":"11","author":"Doria-Rose","year":"2015","journal-title":"Curr. Opin. Virol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1128\/jcm.31.6.1586-1591.1993","article-title":"Identification of four epitopes in hepatitis C virus core protein","volume":"31","author":"Ferroni","year":"1993","journal-title":"J. Clin. Microbiol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1515\/cclm-2017-0754","article-title":"HCV core antigen comes of age: A new opportunity for the diagnosis of hepatitis C virus infection","volume":"56","author":"Galli","year":"2018","journal-title":"Clin. Chem. Lab. Med."},{"key":"B11","volume-title":"Pipeline report. HCV diagnostics","author":"Gay","year":"2020"},{"key":"B12","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1006\/viro.1994.1666","article-title":"Characterization of antigenic determinants in the core antigen of the hepatitis C virus","volume":"205","author":"Goeser","year":"1994","journal-title":"Virology"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1053\/j.gastro.2007.08.005","article-title":"Robust hepatitis C genotype 3a cell culture releasing adapted intergenotypic 3a\/2a (S52\/JFH1) viruses","volume":"133","author":"Gottwein","year":"2007","journal-title":"Gastroenterology"},{"key":"B14","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1002\/hep.22673","article-title":"Development and characterization of hepatitis C virus genotype 1-7 cell culture systems: Role of CD81 and scavenger receptor class B type I and effect of antiviral drugs","volume":"49","author":"Gottwein","year":"2009","journal-title":"Hepatology"},{"key":"B15","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/icb.1995.53","article-title":"Immune response to hepatitis C virus core protein in mice","volume":"73","author":"Harase","year":"1995","journal-title":"Immunol. Cell Biol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1111\/j.1365-2893.1995.tb00035.x","article-title":"Sequence analysis of the hepatitis C virus (HCV) core gene suggests the core protein as an appropriate target for HCV vaccine strategies","volume":"2","author":"Hitomi","year":"1995","journal-title":"J. Viral Hepat."},{"key":"B17","doi-asserted-by":"publisher","first-page":"8929","DOI":"10.3748\/wjg.v19.i47.8929","article-title":"Post-translational modifications of hepatitis C viral proteins and their biological significance","volume":"19","author":"Hundt","year":"2013","journal-title":"World J. Gastroenterol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/0378-1119(94)00782-n","article-title":"Hepatitis C virus core protein: Synthesis, affinity purification and immunoreactivity with infected human sera","volume":"153","author":"Khanna","year":"1995","journal-title":"Gene"},{"key":"B19","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1128\/JCM.00476-17","article-title":"Point-of-Care testing for infectious diseases: Past, present, and future","volume":"55","author":"Kozel","year":"2017","journal-title":"J. Clin. Microbiol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.1111\/trf.13179","article-title":"Sensitivity of hepatitis C virus core antigen and antibody combination assays in a global panel of window period samples","volume":"55","author":"Laperche","year":"2015","journal-title":"Transfusion"},{"key":"B21","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1385\/0-89603-521-2:325","article-title":"Expression and dimerization of hepatitis C virus core protein in E. coli","volume":"19","author":"Lo","year":"1999","journal-title":"Methods Mol. Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/978-3-642-27340-7_5","article-title":"Hepatitis C virus proteins: From structure to function","volume":"369","author":"Moradpour","year":"2013","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1002\/(SICI)1096-9071(199603)48:3<234::AID-JMV4>3.0.CO;2-9","article-title":"Characterization of three novel monoclonal antibodies against hepatitis C virus core protein","volume":"48","author":"Moradpour","year":"1996","journal-title":"J. Med. Virol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"104846","DOI":"10.1016\/j.jcv.2021.104846","article-title":"SARS-CoV-2 rapid antigen test: High sensitivity to detect infectious virus","volume":"140","author":"Nordgren","year":"2021","journal-title":"J. Clin. Virol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"e431","DOI":"10.1016\/S2214-109X(20)30505-2","article-title":"Decentralisation, integration, and task-shifting in hepatitis C virus infection testing and treatment: A global systematic review and meta-analysis","volume":"9","author":"Oru","year":"2021","journal-title":"Lancet Glob. Health"},{"key":"B26","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1007\/s00705-012-1418-4","article-title":"The pan-genotype specificity of the hepatitis C virus anti-core monoclonal antibody C7-50 is contingent on the quasispecies profile of a population","volume":"157","author":"Palmer","year":"2012","journal-title":"Arch. Virol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1080\/15321819508013556","article-title":"Identification of immunodominant epitopes in the core and non-structural region of hepatitis C virus by enzyme immunoassay using synthetic peptides","volume":"16","author":"Park","year":"1995","journal-title":"J. Immunoass."},{"key":"B28","doi-asserted-by":"publisher","first-page":"352","DOI":"10.4254\/wjh.v9.i7.352","article-title":"Future of liver disease in the era of direct acting antivirals for the treatment of hepatitis C","volume":"9","author":"Ponziani","year":"2017","journal-title":"World J. Hepatol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/s00216-008-2287-2","article-title":"Lateral flow (immuno)assay: Its strengths, weaknesses, opportunities and threats. A literature survey","volume":"393","author":"Posthuma-Trumpie","year":"2009","journal-title":"Anal. Bioanal. Chem."},{"key":"B30","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1002\/jmv.1890430112","article-title":"Locations of antibody binding sites within conserved regions of the hepatitis C virus core protein","volume":"43","author":"Sallberg","year":"1994","journal-title":"J. Med. Virol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/0165-2478(92)90089-7","article-title":"Immune response to a single peptide containing an immunodominant region of hepatitis C virus core protein: The isotypes and the recognition site","volume":"33","author":"Sallberg","year":"","journal-title":"Immunol. Lett."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1128\/jcm.30.8.1989-1994.1992","article-title":"Immunodominant regions within the hepatitis C virus core and putative matrix proteins","volume":"30","author":"Sallberg","year":"","journal-title":"J. Clin. Microbiol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1002\/jmv.1890440116","article-title":"Immune responses of blood donors to peptides of various lengths and those with genotypic sequence variations corresponding to the N-terminal portion of the core protein of hepatitis C virus","volume":"44","author":"Sato","year":"1994","journal-title":"J. Med. Virol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1073\/pnas.0711044105","article-title":"Development of JFH1-based cell culture systems for hepatitis C virus genotype 4a and evidence for cross-genotype neutralization","volume":"105","author":"Scheel","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B35","doi-asserted-by":"publisher","first-page":"113024","DOI":"10.1016\/j.biopha.2022.113024","article-title":"Negative impact of HIV infection on broad-spectrum anti-HCV neutralizing antibody titers in HCV-infected patients with advanced HCV-related cirrhosis","volume":"150","author":"Sepulveda-Crespo","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1016\/S0140-6736(19)32320-7","article-title":"Hepatitis C","volume":"394","author":"Spearman","year":"2019","journal-title":"Lancet"},{"key":"B37","doi-asserted-by":"publisher","first-page":"e01957","DOI":"10.1128\/JVI.01957-17","article-title":"Immunogenicity in rabbits of HIV-1 SOSIP trimers from clades A, B, and C, given individually, sequentially, or in combination","volume":"92","author":"Torrents De La Pena","year":"2018","journal-title":"J. Virol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1038\/nm1268","article-title":"Production of infectious hepatitis C virus in tissue culture from a cloned viral genome","volume":"11","author":"Wakita","year":"2005","journal-title":"Nat. Med."},{"key":"B39","doi-asserted-by":"publisher","first-page":"e23755","DOI":"10.1002\/jcla.23755","article-title":"HCV core antigen plays an important role in the fight against HCV as an alternative to HCV-RNA detection","volume":"35","author":"Wang","year":"2021","journal-title":"J. Clin. Lab. Anal."},{"key":"B40","unstructured":"Global health sector strategies on viral hepatitis 2016-2021"},{"key":"B41","unstructured":"Hepatitis C"},{"key":"B42","volume-title":"The global health sector strategies on, respectively, HIV, viral hepatitis and sexually transmitted infections 2022-2030","year":"2021"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1002\/hep.510240505","article-title":"Phylogenetic analysis of hepatitis C virus isolates and their correlation to viremia, liver function tests, and histology","volume":"24","author":"Zeuzem","year":"1996","journal-title":"Hepatology"}],"container-title":["Frontiers in Molecular Biosciences"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmolb.2023.1225553\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T23:17:59Z","timestamp":1689290279000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmolb.2023.1225553\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,13]]},"references-count":43,"alternative-id":["10.3389\/fmolb.2023.1225553"],"URL":"https:\/\/doi.org\/10.3389\/fmolb.2023.1225553","relation":{},"ISSN":["2296-889X"],"issn-type":[{"value":"2296-889X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,13]]},"article-number":"1225553"}}